{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:33:27Z","timestamp":1773448407028,"version":"3.50.1"},"reference-count":180,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2017,9,2]]},"DOI":"10.1080\/1744666x.2017.1332994","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T08:06:49Z","timestamp":1495699609000},"page":"849-866","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":39,"title":["Treatment of adult-onset still\u2019s disease: up to date"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-4008","authenticated-orcid":false,"given":"Dae Hyun","family":"Yoo","sequence":"first","affiliation":[{"name":",","place":["Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,6,5]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.974881"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.058"},{"key":"e_1_3_2_5_1","first-page":"47","article-title":"Adult-onset Still\u2019s disease: clinical, serological and therapeutic considerations","volume":"31","author":"Iliou C","year":"2013","unstructured":"Iliou C, Papagoras C, Tsifetaki N, et al. Adult-onset Still\u2019s disease: clinical, serological and therapeutic considerations. Clin Exp Rheumatol. 2013;31:47\u201352.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.971052"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.02.010"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.011"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2487-4"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.11.002"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000021"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-015-0047-3"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.05.010"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8561-9"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201991"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134254"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207818"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket250"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.08.003"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.992949"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27532"},{"key":"e_1_3_2_23_1","article-title":"[Autoinflammatory syndromes\/fever syndromes]","volume":"62","author":"Schedel J","year":"2011","unstructured":"Schedel J, Bach B, Kummerle-Deschner JB, et al. [Autoinflammatory syndromes\/fever syndromes]. Hautarzt. 2011;62:389-401; quiz 402.","journal-title":"Hautarzt"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202470"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202469"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-010-0160-9"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.2.144"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S64951"},{"key":"e_1_3_2_29_1","first-page":"S168","article-title":"Use of methotrexate in adult-onset Still\u2019s disease","volume":"28","author":"Manger B","year":"2010","unstructured":"Manger B, Rech J, Schett G. Use of methotrexate in adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2010;28:S168\u2013171.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq284"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.013680"},{"key":"e_1_3_2_32_1","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still\u2019s disease","volume":"30","author":"Choi JH","year":"2003","unstructured":"Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still\u2019s disease. J Rheumatol. 2003;30:2422\u20132427.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew300"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.032"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.04.018"},{"key":"e_1_3_2_36_1","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi M","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u2013430.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2765-5"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X16638667"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0138-5"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050030"},{"key":"e_1_3_2_41_1","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still\u2019s disease in Korea","volume":"21","author":"Joung CI","year":"2003","unstructured":"Joung CI, Lee HS, Lee SW, et al. Association between HLA-DR B1 and clinical features of adult onset Still\u2019s disease in Korea. Clin Exp Rheumatol. 2003;21:489\u2013492.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780280207"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001554"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/879020"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/819467"},{"key":"e_1_3_2_46_1","first-page":"181","article-title":"Relationship between serum interleukin-17 level and inflammatory bowel disease","volume":"30","author":"Liu QL","year":"2016","unstructured":"Liu QL, Huang L, Zhao QJ, et al. Relationship between serum interleukin-17 level and inflammatory bowel disease. J Biol Regul Homeost Agents. 2016;30:181\u2013188.","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38672"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090662"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111500"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.09.007"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39295"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-185"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199103000-00004"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100247"},{"key":"e_1_3_2_55_1","first-page":"298405","article-title":"Ferritin in adult-onset still\u2019s disease: just a useful innocent bystander?","volume":"2012","author":"Mehta B","year":"2012","unstructured":"Mehta B, Efthimiou P. Ferritin in adult-onset still\u2019s disease: just a useful innocent bystander?. Int J Inflam. 2012;2012:298405.","journal-title":"Int J Inflam"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2013.824023"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22194"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.004"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu416"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140651"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2220-8"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1037287"},{"key":"e_1_3_2_63_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cei.12738","article-title":"The CD68(+)\/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still\u2019s disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis","volume":"183","author":"Ruscitti P","year":"2016","unstructured":"Ruscitti P, Ciccia F, Cipriani P, et al. The CD68(+)\/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still\u2019s disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis. Clin Exp Immunol. 2016;183:397\u2013404.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3314-x"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0773-4"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0423-2"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8563-7"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.644325"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2009.09.010"},{"key":"e_1_3_2_70_1","first-page":"933","article-title":"Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still\u2019s disease","volume":"26","author":"Priori R","year":"2008","unstructured":"Priori R, Ceccarelli F, Barone F, et al. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2008;26:933\u2013937.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.973659"},{"issue":"102","key":"e_1_3_2_72_1","first-page":"64","article-title":"Efficacy of tocilizumab therapy in Korean patients with adult-onset Still\u2019s disease: a multicentre retrospective study of 22 cases","volume":"34","author":"Song ST","year":"2016","unstructured":"Song ST, Kim JJ, Lee S, et al. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still\u2019s disease: a multicentre retrospective study of 22 cases. Clin Exp Rheumatol. 2016;34(Suppl 102):64\u201371.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2105-2"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2381-5"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq397"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0738-8"},{"key":"e_1_3_2_78_1","first-page":"2345","article-title":"Clinical characteristics, treatment, and outcome of adult onset Still\u2019s disease in southern Chinese","volume":"25","author":"Mok CC","year":"1998","unstructured":"Mok CC, Lau CS, Wong RW. Clinical characteristics, treatment, and outcome of adult onset Still\u2019s disease in southern Chinese. J Rheumatol. 1998;25:2345\u20132351.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4771"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S73428"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38398"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0126-0"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200309000-00009"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21901"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3308-8"},{"key":"e_1_3_2_86_1","first-page":"16634","article-title":"Clinical features and prognosis of adult-onset Still\u2019s disease: 75 cases from China","volume":"8","author":"Liu Z","year":"2015","unstructured":"Liu Z, Lv X, Tang G. Clinical features and prognosis of adult-onset Still\u2019s disease: 75 cases from China. Int J Clin Exp Med. 2015;8:16634\u201316639.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_2_87_1","article-title":"Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers","author":"Yamashita T","year":"2016","unstructured":"Yamashita T, Ishii A, Oda A, et al. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers. Case Rep Med. 2016;2016:5656320.","journal-title":"Case Rep Med"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3178-0"},{"key":"e_1_3_2_89_1","first-page":"163952","article-title":"Successful treatment with intravenous cyclophosphamide for refractory adult-onset still\u2019s disease","volume":"2015","author":"Tsuji Y","year":"2015","unstructured":"Tsuji Y, Iwanaga N, Adachi A, et al. Successful treatment with intravenous cyclophosphamide for refractory adult-onset still\u2019s disease. Case Rep Rheumatol. 2015;2015:163952.","journal-title":"Case Rep Rheumatol"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K084"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E425"},{"key":"e_1_3_2_92_1","first-page":"295","article-title":"Intravenous immunoglobulin in adult Still\u2019s disease refractory to non-steroidal anti-inflammatory drugs","volume":"16","author":"Vignes S","year":"1998","unstructured":"Vignes S, Wechsler B, Amoura Z, et al. Intravenous immunoglobulin in adult Still\u2019s disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 1998;16:295\u2013298.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_93_1","first-page":"245","article-title":"High toxicity of sulfasalazine in adult-onset Still\u2019s disease","volume":"18","author":"Jung JH","year":"2000","unstructured":"Jung JH, Jun JB, Yoo DH, et al. High toxicity of sulfasalazine in adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2000;18:245\u2013248.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1277-9"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)35272-3"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0569-6"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_110"},{"key":"e_1_3_2_98_1","first-page":"329","article-title":"Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy","volume":"19","author":"Cavagna L","year":"2001","unstructured":"Cavagna L, Caporali R, Epis O, et al. Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329\u2013332.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.90003.iii55"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.024026"},{"key":"e_1_3_2_101_1","first-page":"121","article-title":"Prolonged efficacy of infliximab for refractory adult-onset Still\u2019s disease","volume":"23","author":"Dilhuydy MS","year":"2005","unstructured":"Dilhuydy MS, Vatan R, Etienne G, et al. Prolonged efficacy of infliximab for refractory adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2005;23:121\u2013122.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1331-8"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0477-9"},{"key":"e_1_3_2_104_1","first-page":"923497","article-title":"Successful use of higher-dose etanercept for multirefractory systemic flare of adult-onset still\u2019s disease with liver failure with no response to tocilizumab therapy","volume":"2013","author":"Naniwa T","year":"2013","unstructured":"Naniwa T, Tamechika S, Iwagaitsu S, et al. Successful use of higher-dose etanercept for multirefractory systemic flare of adult-onset still\u2019s disease with liver failure with no response to tocilizumab therapy. Case Rep Rheumatol. 2013;2013:923497.","journal-title":"Case Rep Rheumatol"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.08.003"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207588"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2012.10.372"},{"key":"e_1_3_2_109_1","first-page":"2134","article-title":"Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies","volume":"54","author":"Cavalli G","year":"2015","unstructured":"Cavalli G, Dinarello CA. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015;54:2134\u20132144.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0228-7"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111549"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3366"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076034"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.026617"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21061"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.04.002"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066381"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-009-0254-1"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108068"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1677"},{"key":"e_1_3_2_121_1","first-page":"892","article-title":"Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still\u2019s disease","volume":"34","author":"Quartuccio L","year":"2007","unstructured":"Quartuccio L, De Vita S. Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still\u2019s disease. J Rheumatol. 2007;34:892\u2013893.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30128"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1459-6"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2013.10.008"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/317820"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev416"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-015-0123-8"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2016.1204910"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.03.004"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000082"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.12.011"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4159"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38699"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23687"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-8-201210160-00003"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33412"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201409"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2013.771986"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202310"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10620"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20319"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130881"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu019"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-010-0348-9"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12324"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2016.1221875"},{"key":"e_1_3_2_148_1","first-page":"100","article-title":"Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still\u2019s disease","volume":"23","author":"Amenomori M","year":"2005","unstructured":"Amenomori M, Migita K, Miyashita T, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still\u2019s disease. Clin Exp Rheumatol. 2005;23:100\u2013102.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_149_1","first-page":"297","article-title":"Successful tocilizumab therapy in seven patients with refractory adult-onset Still\u2019s disease","volume":"26","author":"Altinok G","year":"2016","unstructured":"Altinok G, Levine M, Dhar JP, et al. Successful tocilizumab therapy in seven patients with refractory adult-onset Still\u2019s disease. Case Rep Rheumatol. 2016;26:297\u2013301.","journal-title":"Case Rep Rheumatol"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.899178"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.02.006"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5656320"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1179-7"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-12-200606200-00003"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39234"},{"key":"e_1_3_2_156_1","first-page":"265","article-title":"Efficacy of abatacept in a refractory case of adult-onset Still\u2019s disease","volume":"28","author":"Quartuccio L","year":"2010","unstructured":"Quartuccio L, Maset M, De Vita S. Efficacy of abatacept in a refractory case of adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2010;28:265\u2013267.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31822c53ad"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu027"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2016.888"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.047621"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-012806"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.046904"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091046"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000381996.69261.71"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.3"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208982"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1086\/685112"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2004.19.1.137"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2015.3299"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3545-9"},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121098"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.04.011"},{"key":"e_1_3_2_174_1","first-page":"758","article-title":"Severe systemic inflammatory response syndrome in a patient with adult onset Still\u2019s disease treated with the anti-IL1 drug anakinra: a case report","volume":"25","author":"Guignard S","year":"2007","unstructured":"Guignard S, Dien G, Dougados M. Severe systemic inflammatory response syndrome in a patient with adult onset Still\u2019s disease treated with the anti-IL1 drug anakinra: a case report. Clin Exp Rheumatol. 2007;25:758\u2013759.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2014.17.94.3386"},{"issue":"5","key":"e_1_3_2_176_1","article-title":"Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis","volume":"13","author":"Singh JA","year":"2016","unstructured":"Singh JA, Hossain A, Tanjong Ghogomu E, et al. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2016 May 13;(5):CD012183.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109071"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310476"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112072"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvv069"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39714"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060635"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2017.1332994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:01:37Z","timestamp":1770393697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2017.1332994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":180,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,2]]}},"alternative-id":["10.1080\/1744666X.2017.1332994"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2017.1332994","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-12-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}